ZPD-2 inhibits the aggregation of C-terminally truncated and full-length alpha-synuclein. ZPD-2 inhibits the formation and fibrillation of alpha-Syn, thereby preventing its propagation. ZPD-2 can be used in research of Parkinsons disease[1].
Molecular Weight:
424.40
Formula:
C18H15F3N4O3S
Target:
alpha-synuclein
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted